The National Agency for Food and Drug Administration and Control (NAFDAC) has assured Nigerians that genetically modified ...

Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

Vidofludimus Calcium Substantially Reduced 24-Week Confirmed Disability Worsening in Phase 2 CALLIPER Trial in Overall Progressive Multiple Sclerosis ...

Company Announcement, European Regulatory News, GlobeNewswire, Pharmaceuticals | Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange L ...

Variety’s 2025 class of New Leaders is an antidote to that type of thinking, proving that a time of contraction and ...

The community of Cardigan celebrates the successful purchase and transformation of the Tabernacl Chapel into a vibrant ...

Moves in Charlotte must be planned in conjunction with the weather. The weather in the city has moods, and if you are moving in a rush, the last thing you need is a humid meltdown or a winter surprise ...

Saudi Arabia’s leading purpose-driven healthcare and wellbeing Company, today reported its financial results for the second ...

Procter & Gamble (PG) reported fourth quarter results, warning that it will take a $1 billion hit from tariffs in full-year ...

The American Tort Reform Association (ATRA) today branded the Florida House of Representatives a "Lawsuit Inferno" in its latest Legislative HeatCheck report, ...

Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the Middle East. QRX003 Peeling Skin Syndrome Clinical Program Cont ...

Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., ...